Your Email:

Your Name:

To:
(Separate email addresses with a comma)

Subject:

Message:
Thought you might be interested in this article: Interpretation Blues? FDA Releases Draft Guidance On 21CFR Part11 Pharmaceutical Technology Europe magazine recently published an article of interest to those in the life sciences industry entitled The End of the 21 CFR Part 11 Controversy and Confusion?. The article outlines new draft guidance, issued by the U.S. Food and Drug Administration, on the intended scope and application of 21 CFR Part 11. Authored by Gordon B. Richmond, the article examines the confusion the regulation has caused in the pharmaceutical industry, and discusses the issues raised by the new draft guidance. Richmond’s article concludes: “FDA’s recent draft guidance raises a number of new fundamental questions, and sets the stage for more controversy and confusion regarding Part 11 and how it will be interpreted and enforced. Given this reality, one… Read the rest: http://www.thecontentwrangler.com/article/69/

Please enter the word you see in the image below: